Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
AbbVie said on Monday it would partner with Chinese drug developer RemeGen for an experimental treatment targeting solid ...
19hon MSN
JAC class 9 registration 2026 ends today: Direct link, steps to register without late fee here
The Jharkhand Academic Council will close Class 9 registration for 2026 today, January 12. Registrations not approved by the ...
CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading ...
New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 followin ...
DMN sports columnist Kevin Sherrington’s weekly newsletter hits on all of the latest sports topics around North Texas.
PVP Labs, a biotechnology company advancing next-generation peptide-based therapeutics, today announced its participation in the JP Morgan Healthcare Conference 2026, where the company will engage ...
Completed concept studies for expansion of South Carolina and Nevada hubs, increasing total HyProMag USA magnet and alloy production from 1,552 metric tons NdFeB to 4,656 metric tons NdFeB per annum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback